PBPH ETF Analysis
Bu sayfa İngilizce aslından yapay zekâ ile çevrildi; İngilizce sürüm esastır. İngilizce sürümü oku
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir.
PBPH ETF has a last stored price of $27.82, as of the Oct 2, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.
In the stored portfolio snapshot, the largest listed holding is Eli Lilly and Co (LLY) at 13.85%.
PBPH ETF — Price, Holdings & Analysis
ETF Genel Bakış
Risk Metrikleri
- Beta: 0.00
PBPH hangi varlıkları tutuyor?
| Varlık | Ağırlık |
|---|---|
| Eli Lilly and Co (LLY) | 13.85% |
| Johnson & Johnson (JNJ) | 9.35% |
| AbbVie Inc (ABBV) | 6.33% |
| Novartis AG Registered Shares (NOVN.SW) | 5.32% |
| Roche Holding AG (ROG.SW) | 5.27% |
| Merck & Co Inc (MRK) | 4.89% |
| AstraZeneca PLC (AZN.L) | 4.83% |
| Amgen Inc (AMGN) | 4.56% |
| Gilead Sciences Inc (GILD) | 3.98% |
| Pfizer Inc (PFE) | 3.42% |
Bu fon verileri 45 günden eski; güncel varlıkları ihraççıdan doğrulayın.
Temettü Verimi
Sorular & Cevaplar
What is PBPH and what does it track?
PBPH is an exchange-traded fund that aims to provide investors with targeted exposure to the largest global pharmaceutical companies. The fund achieves this by tracking an index composed of the 10 largest companies in the global pharmaceutical sector.
As of 2026-03-15, PBPH's top holdings include Eli Lilly and Co, Johnson & Johnson, and AbbVie Inc.
What are the top holdings in PBPH?
As of 2026-03-15, PBPH's top holdings are concentrated in leading global pharmaceutical companies. The top three holdings are Eli Lilly and Co (13.85%), Johnson & Johnson (9.35%), and AbbVie Inc (6.33%).
These companies represent a significant portion of the fund's assets, reflecting PBPH's strategy of focusing on the largest players in the pharmaceutical industry. Investors should be aware of the concentration risk associated with these top holdings.
Is PBPH a good long-term investment?
Whether PBPH is a suitable long-term investment depends on an individual investor's specific financial goals, risk tolerance, and investment horizon. PBPH offers targeted exposure to the global pharmaceutical industry, which may appeal to investors seeking growth in this sector.
However, the fund's concentrated portfolio and sector-specific risks should be carefully considered.
How does PBPH compare to similar ETFs?
PBPH distinguishes itself through its highly concentrated strategy of holding only the 10 largest global pharmaceutical companies. This contrasts with broader healthcare ETFs that may include a wider range of companies across various healthcare sub-sectors.
When comparing PBPH to similar ETFs, factors such as expense ratios, AUM, and investment strategies may be worth researching.
Does PBPH pay dividends?
According to the provided data, PBPH has a dividend yield of 0.00% as of 2026-03-15. This indicates that the fund does not currently distribute dividends to its shareholders.
Investors seeking income-generating investments may need to consider alternative ETFs with higher dividend yields. However, PBPH's focus on capital appreciation within the pharmaceutical sector may still be attractive to investors with different investment goals.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
Bu sayfayı makine yazdı, sayfa sayfa insan denetiminden geçmedi. Editoryal denetim sistemiktir: kurallar ve kaynaklar denetlenir, tek tek sayfalar denetlenmez.